Search - tctmd.com

Displaying 1 - 20 of 52

Sort: Relevancy | Date

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

L.A. McKeown

February 14, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Todd Neale

March 15, 2024

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

L.A. McKeown

November 20, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

L.A. McKeown

January 20, 2022

News Daily News

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

Todd Neale

December 27, 2021

News Daily News

Marijuana Ups Bleeding, CVA Risks in PCI Patients: Registry Data

Caitlin E. Cox

August 16, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Conference News ESC 2020

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

Caitlin E. Cox

September 04, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Conference News CRT 2020

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

L.A. McKeown

February 24, 2020

News Conference News SCAI 2019

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Yael L. Maxwell

May 24, 2019

News Daily News

Patients Stop CVD Medications When Their Pharmacy Closes

Michael O'Riordan

April 19, 2019

News Daily News

NOACs Significantly Curb Risk of VTE in Cancer Patients

L.A. McKeown

December 06, 2018

News Daily News

Research Series Sheds Light on Questions Surrounding Stroke Risk in Women

L.A. McKeown

February 09, 2018

Advertisement

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

January 2025 Dispatch for the CV Team

May 2024 Dispatch for the CV Team

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

AHA Selects 2023’s Leading Cardiovascular Research

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

Marijuana Ups Bleeding, CVA Risks in PCI Patients: Registry Data

Roughly 80% of ESC Guideline Writers Have Financial COIs

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Patients Stop CVD Medications When Their Pharmacy Closes

NOACs Significantly Curb Risk of VTE in Cancer Patients

Research Series Sheds Light on Questions Surrounding Stroke Risk in Women

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content